--- title: 'Software Daily Summary: What Happened on October 19, 2026' headline: DASH quality-data platform becomes commercially available description: The software turns pharmaceutical quality certificates into structured data. A project demonstration found it could shorten approval cycles by up to 90%. url: https://thebench.bio/news/software/2026-10-19 topic: software date: '2026-10-19' covers: - '2026-10-19' date_published: '2026-10-19T12:02:37Z' date_modified: '2026-10-19T12:02:37Z' tags: - Regulatory sources: 1 publisher: TheBench.Bio --- # Software Daily Summary: What Happened on October 19, 2026 **DASH quality-data platform becomes commercially available** The software turns pharmaceutical quality certificates into structured data. A project demonstration found it could shorten approval cycles by up to 90%. ## Today in brief DASH is now commercially available after a project with GSK, the University of Cambridge and CPI. [1] In a demonstration, the platform shortened review-to-approval cycles by as much as 90%. [1] ## The day in numbers - **Up to 90%**: Maximum reduction in review-to-approval cycle time reported in the project demonstration. [1] ## Also published - [How Compressing Time From Data Capture to Insight Changes Trial Risk Management](), Applied Clinical Trials - [AI that understands, reasons and acts: Closing the integration gap in enterprise imaging](), MedTech Dive - [Editor’s pick: Bioptimus](), Nature Biotechnology ## Sources 1. [Digital platform cuts pharmaceutical quality-record approval times by up to 90%](), Pharmafile, 2026-10-19 --- TheBench.Bio wrote this from the reporting cited above, with a language model drafting and editing. [1]: